Evogene (EVGN) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q4 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $580 thousand versus the consensus estimate of $893.33 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone beats profit view but misses on revenue
- Activist Corvex seeks Whitbread board seat over strategy concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
